Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Flumazenil manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Germany

Clear all

1 products found

flumazenil

Solution for injection 0.5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Croatia
Manufacturer #12799
It is a generic pharmaceutical producer and sales organization based in Western Europe that was created in the 1990s. The company's broad portfolio includes high-quality complex dosage forms, such as liquid, injectable, dry powder, and lyophilisate items, and it specializes in supplying hospitals and pharmacies with selected products. It continues to grow steadily, and its focus on high-quality items, excellent service, and the development of strong relationships remains strong, attesting to the company's reputation.

Manufacturer usually replies in 5 days

Flumazenil Manufacturer

Flumazenil is a medical substance and a pharmaceutical drug that is used to invert the effects of a benzodiazepine (BENZ-oh-dye-AYZ-e-peen) medication such as Xanax, Valium, Versed, Tranxene It is applied to help you to wake up after an operation or medical procedure in which a benzodiazepine was used as a medicine. This is further used to treat benzodiazepine overdose in adults. Moreover, it is used for purposes not recorded in this medication guide

How does Flumazenil work

The medical substance, flumazenil is a benzodiazepine antagonist. It competitively restrains the activity of benzodiazepine and non-benzodiazepine substances that helps to interact with benzodiazepine receptors on the GABA/benzodiazepine receptor complex. It can also invert the cover of benzodiazepines to benzodiazepine receptors.

The Wholsale Price of Flumazenil

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the cost. In the US, The wholesale cost for flumazenil intravenous solution (0.1 mg/mL) is around $20 for a supply of 10 milliliters, depending on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Flumazenil offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Flumazenil manufacturers and Flumazenil suppliers that you are looking for. These also enable you to check the dossier status of Flumazenil, and the GMP approvals of the different variants of Flumazenil. Also, each manufacturer or supplier product description contains essential information about Flumazenil including clinical data, stability zones, countries where Flumazenil is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are on boarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.